Latest News
|
NHIA applauds Senator Isakson for leadership on home infusion Dec 4, 2019
The National Home Infusion Foundation (NHIF) has announced a public comment period for the next phase of its Benchmarking Program that includes two new metrics to launch in 2020. NHIA members are encouraged to review the draft benchmarking participation guides for collecting industry-wide outcome data for 30-day Rehospitalizations, and the Status at Discharge for patients receiving infusions in the home or suite setting. A revised definition for the Discharge Reasons is also proposed to support data collection for the new benchmarking metrics. Deadline to submit comment is December 31. Send comments to nhifdata@nhia.org. Dec 3, 2019
NHIA announces 2020 Annual Conference in Denver Nov 15, 2019
Important Facts about Parenteral Selenium (Selenious Acid) Nov 6, 2019
NHIA expresses disappointment on CMS home health payment rule Nov 1, 2019
White House Releases Proposed Rules on Medicare Value-Based Arrangements Oct 23, 2019
NHIA calls on American Reagent to Revise Pricing/Stability for Selenious Acid Oct 4, 2019
NHIA members share insight on home and specialty infusion on Capitol Hill Oct 2, 2019
NHIF announces first-ever home infusion industry patient satisfaction benchmarks Sept 12, 2019
NHIA and IACP announce co-location of 2020 annual conferences in Denver Sept 10, 2019
NHIA Submits Comments on CMS’ Proposed CY 2020 Home Health Payment Rule Sept 9, 2019
NHIA Submits Comments on Administration's Patients Over Paperwork Initiative Aug 20, 2019
NHIA Submits Comments to CMS on Changes to Part B DMEPOS Ig Policy Aug 20, 2019
NHIA congratulates Option Care and BioScrip on successful merger Aug 8, 2019
NHIA 2020 Annual Conference registration now open Aug 5, 2019
NHIA Denounces CMS Proposed Home Infusion Rule Read a Summary of the Proposed Rule July 16, 2019 NHIA Position Paper: Home Infusion Reimbursement Must Reflect Essential Specialized Pharmacy Professional Services Read the Position Paper May 21, 2019 NHIA Takes Legal Action Against CMS’ Transitional Payment Read the complaint Feb. 15, 2019 HHS Proposed Rule Takes Aim at Drug Rebates from Manufacturers to Health Plans/PBMs, Proposes Safe Harbors to Pass Savings to Consumers and Protect Some Manufacturer-PBM Payments Feb. 1, 2019 NHIA Comments on CMS proposal to modernize Part D and Medicare Advantage to lower drug prices Jan. 25, 2019 Charron Named COO; Noyes Promoted to Senior Vice President, Reimbursement Policy Jan. 9, 2019 NHIA Submits Comments to CMS on Home infusion Transitional Payment Dec. 27, 2018 NHIA Accepting Nominations for Gene Graves Award Dec. 13, 2018 NHIA Submits Comments to FDA on Draft MOU Addressing Certain Distributions of Compounded Drug Products Between States and FDA Dec. 10, 2018 Talk Infusion Webinar — Home Infusion Transitional Payment: Staying the Course Dec. 4, 2018 NHIA To Submit Comments on Draft Memorandum of Understanding Addressing Certain Distributions of Compounded Drug Products Between States and the FDA; Comment Deadline is Monday, December 10 Dec. 7, 2018 CMS Issues Details on Transitional Payment to Begin January 1, 2019. Access MLN Matters MM10836 - Temporary Transitional Payment for Home Infusion Therapy Services for CYs 2019 and 2020 Dec. 4, 2018 Sullivan Named NHIA President and CEO Dec. 4, 2018 |
|
|
|
 |
Be a part of the infusion field
NHIA Consultant Network Database
NHIA Advertisement & Sponsorship Opportunities
Talk Infusion—The NHIA Membership Forum 
INFUSION Express—NHIA's electronic newsletter (past issues)
2019 NHIA National Coding Standard for Home Infusion Claims under HIPAA
NHIA National Definition of Per Diem
= Member Only